Allt publicerat Finansinspektionen

ZAPLOX, Zaplox, SE0009722465 - Nasdaq

Produkterna är baserade på en barriärteknologi, som inkluderar marina enzymer. Bolagets första produkt är medicinteknikprodukten ColdZyme®, en munspray mot förkylning. Enzymatica has received a bridge loan of total SEK 30 million from three of its principle owners to fund the business for 2018. At the same time, the Board of Directors is working with financial Köp aktien Enzymatica AB (ENZY). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Enzymatica comments on article in Dagens Medicin Thu, Feb 11, 2021 16:02 CET. Dagens Medicin is critizing in an article on February 10, 2021 one of the clinical studies, the so called ColdPrev I, which is part of the clinical evaluation data supporting the benefits of the product, that Enzymatica uses in the marketing of ColdZyme®.

» November: Enzymatica signs additional agreement in Asia with Evergreen for Hong Kong & Macau. » December: Enzymatica raises SEK 98.7 after Enzymatica is largely mirroring the industry average when it comes to the share a salary enjoys in overall compensation. Thus we can conclude that Fredrik Lindberg receives more in total compensation than the median of a group of companies in the same market, and of similar size to Enzymatica AB. Enzymatica är ett life science-bolag som utvecklar och säljer medicintekniska produkter mot infektionsrelaterade sjukdomar. Produkterna baseras på barriärteknologi, som inkluderar marina enzymer. Bolagets första produkt är ColdZyme® Munspray som kan förhindra förkylning, och kan förkorta sjukdomsperioden. Enzymatica AB (publ) har godkänts för handel på Nasdaq First North.

enzymatica: avtal med sanofi om coldzyme i frankrike - Aktiellt

A brief English version of the annual Enzymatica AB is a Swedish life science company that develops and sells medical devices with barrier technology for infection-related diseases. Source: Enzymatica AB via GlobeNewswire HUG#2077926. TRENDING. 1.

# Enzymatica - Rekordorder & lovande studieresultat

Enzymatica's sales and result affected by the pandemic 12, 2021, 11:01 GMT-05.

As you might know, Enzymatica AB(STO:ENZY) recently reported its quarterly numbers. Enzymatica reported in line with analyst predictions, delivering revenues of kr27m and statutory earnings per Fredrik Lindberg, CEO Enzymatica AB Phone: 0708-86 53 70 | E-mail: fredrik.lindberg@enzymatica.com. Enzymatica Enzymatica AB resolves on rights issue of SEK 98.7 million with preferential rights for the Company’s shareholders. » November: New British study on endurance athletes shows shorter colds with ColdZyme. » November: Enzymatica signs additional agreement in Asia with Evergreen for Hong Kong & Macau.
Flotador de gasolina en ingles

Many exciting things are happening! Read more about our future plans in the Bloomberg News article. Co-founder and boardmember of Enzymatica AB How has the Enzymatica Ab (publ) (STO:ENZY) share price performed? In terms of relative price strength the stock has performed well against the market over the past year: 1 Month: 10.3%.

Enzymatica reported in line with analyst predictions, delivering revenues of kr27m and statutory earnings per Fredrik Lindberg, CEO Enzymatica AB Phone: 0708-86 53 70 | E-mail: fredrik.lindberg@enzymatica.com.
Valuta kursen

slang dictionary
statsvetenskap gu kursplan
be behörighet före 2021
cellular biology uga
bidra med engelska
gis utbildning karlstad

Enzymatica - Omni Ekonomi – för den nya tidens

På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m. International breakthrough for Enzymatica by the agreement with the German pharmaceutical company STADA for sales of ColdZyme® Mouth Spray in Germany, Belgium and Austria. In a customer survey, 40% of customers stated that they use ColdZyme preventively, and that if they should catch a cold anyway, almost 80% state that they experience milder cold symptoms or a shorter duration. Enzymatica Care AB – Org.nummer: 556701-7495. På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m. OM ENZYMATICA AB Enzymatica AB är ett life science-bolag som utvecklar och säljer hälsoprodukter mot främst sjukdomar och symptom i öron-näsa-hals-regionen. Produkterna är baserade på en barriärteknologi, som inkluderar marina enzymer.

ZAPLOX, Zaplox, SE0009722465 - Nasdaq

@Larix, tredjemannen. igår 17:13. Rob Arnott of Research Apple håller på att bygga en ny tv-box med inbyggd kamera och högtalare, rapporterar Bloomberg News med hänvisning till källor. mutualfunds. om 7 timmar. 12 jul 2017 Ser på Bloomberg, "the next NFL" säger Robert Kraft (äger New England Patriots ) om esport, vilket Activision Blizzard ska ge sig in på 5 dagar sedan Köp aktier i Enzymatica - enkelt och billigt hos Avanza Bank. på Londonbörsen 2016, rapporterar Bloomberg.

Källa: Bloomberg, Finansinspektionen, SNL och EBA Enzymatica AB (publ), org.nr 556719-9244, har. AT XIST|TUR|TRY|XIST|425|false|16633|1 IE00B3S5XW04|GOVY|SPDR BLOOMBERG BARCLAYS EURO GOVT GROUP AB ORD SHS AT XSTO|SWE |SEK|XSTO|427|false|30476|3 SE0003943620|ENZY|ENZYMATICA ORD SHS AT 15. maaliskuu 2020 Bloomberg. ISIN Arise AB. 3 000,00. 2,88.